IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Arvee Laboratories (India) IPO is a Fixed Price IPO listing on NSE EMERGE exchange, with an ipo size of ₹ 8.91 Cr. The company is based in Ahmedabad and caters to Chemical - Speciality sector. Sarthi Capital Advisors is the merchant banker of Arvee Laboratories (India) IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st December 2017.
Arvee Laboratories (India) IPO open date is 9th February 2018 and close date is 14th February 2018. IPO Allotment Date is 30th November -0001 and Listing date is 22nd February 2018.
IPO
Size:
₹ 8.91 Cr.
Avg IPO Size (Sector Based)
: ₹
21.01 cr.
Sector: Chemical - Speciality
SME
IPO so far:
7
Merchant Banker:
Sarthi Capital
SME
IPO by BRLM so far:
48
City:
Ahmedabad
SME
IPO so far:
180
Revenue (annualised):
₹
39.60
cr. 
PE
Ratio:
52.00x
Average Sector PE Ratio: 15.57x
Arvee Laboratories (India) IPO size is ₹ 8.91 Cr. with IPO price of ₹ 61.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Sarthi Capital Advisors Private Limited is the book-running lead manager of the Arvee Laboratories (India) IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Wealth First Portfolio Managers Private Limited for Arvee Laboratories (India) IPO.
Arvee Laboratories (India) IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Arvee Laboratories (India) IPO, based in Ahmedabad, operates in the Chemical - Speciality sector with a focus on specialty chemicals. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Arvee Laboratories (India) IPO size is ₹ 8.91 Cr. with fresh issue size of ₹ 8.91 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Arvee Laboratories (India) IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Arvee Laboratories (India) IPO allotment status on the registrars website, Bigshare Services Private Limited . Arvee Laboratories (India) IPO refund dates are 30th November -0001.
Arvee Laboratories (India) IPO is expected to be listed on 22nd February 2018.
The upper price band for the Arvee Laboratories (India) IPO is set at ₹ 61.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Arvee Laboratories (India) IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Arvee Laboratories (India) IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 14th February 2018. After submission, funds are blocked until the basis of allotment of Arvee Laboratories (India) IPO is finalised.
The merchant banker for Arvee Laboratories (India) IPO is Sarthi Capital Advisors Private Limited . Sarthi Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Arvee Laboratories (India) IPO RHP for further details.
The registrar for Arvee Laboratories (India) IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Arvee Laboratories (India) IPO through their official website or helpline.
Arvee Laboratories (India) IPO was subscribed 2.90 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 8.91 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.01 Cr.
Sector: Chemical - Speciality
SME
IPO so far:
7
Merchant Banker:
Sarthi Capital
SME
IPO by BRLM so far:
48
City:
Ahmedabad
SME
IPO so far:
180
Revenue (annualised):
₹ 39.28 cr.
PE
Ratio:
52.00x
Average Sector PE Ratio: 15.57x
Arvee Laboratories (India) IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Arvee Laboratories (India) Financial Review Page
Merchant Banker(s) of Arvee Laboratories (India) IPO: Sarthi Capital Advisors Private Limited
Arvee Laboratories (India) IPO subscription was 2.90 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Arvee Laboratories (India) IPO listed at a listing price of 62.50 against the offer price of 61.00.
The current market price of Arvee Laboratories (India) is 161.17.
Why Us?
